The push toward value-based care will drive interest in clinical decision support systems, according to a report by business consulting firm Frost & Sullivan.
Support systems that provide clinicians with individualized health information will see strong growth as healthcare organizations become more focused on meeting quality performance measures and transitioning away from volume-based care.
"The introduction of value-based reimbursements and quality performance measures will increase the value of evidence-based data to document a clinical rationale and support medical decision making," said Victor Camlek, digital health principal analyst at Frost & Sullivan.
In total, Frost & Sullivan estimated the U.S. clinical decision support system market will be valued at $4.97 billion by 2021.
However, these systems will hinge on information available in EHRs, as clinical decision support relies on large volumes of data to inform point-of-care feedback. Healthcare organizations should be able leverage growing amounts of patient data, but lack of EHR interoperability may hinder this exchange.